# HeartSciences Inc. (HSCSW) — merger/definitive [announced]
Source: SEC API (secapi.ai) · situation sit_660eed2bc6b640ff3698 · retrieved 2026-08-11T15:49:18.105Z

## Overview
HeartSciences Inc. is a healthcare information technology company focused on advancing electrocardiography (ECG/EKG) through the integration of artificial intelligence; its MyoVista Insights platform is a device-agnostic ECG management system, and its MyoVista wavECG device is under FDA review for 510(k) clearance.

HeartSciences Inc., a healthcare information technology company focused on electrocardiography and artificial intelligence, entered into a definitive merger agreement with Fortitude Mining Holdings, Inc. on June 23, 2026, to combine in an all-stock transaction. Under the proposed transaction, HeartSciences will issue approximately 107.6 million shares of a new Class V Common Stock to Digital Currency Group (DCG), Fortitude's parent company. The pro forma combined entity will have total shareholders' equity of $70.0 million. The transaction is subject to HeartSciences shareholder approval at a special meeting, and the parties have also proposed a reverse stock split authorization at a ratio between 1-for-2 and 1-for-5 to satisfy Nasdaq listing requirements for the combined company.

## Terms
- Counterparty: Fortitude Mining Holdings, Inc. · Consideration: stock

## Key dates
- Announced 2026-07-27

## Timeline
- 2026-07-27 · 8-K (0001213900-26-081825): 8-K - HeartSciences Inc. — *Company Overview We are a healthcare information technology company focused on advancing electrocardiography ("ECG" or "EKG") through the integration of artificial intelligence ("AI").* On July 27, 2026, HeartSciences Inc. entered into Amendment No. 1 to its Agreement and Plan of Merger with Fortitude Mining Holdings, Inc., Fortitude Mining HoldCo, LLC, and Cordis Acquisition, LLC (HeartSciences' merger subsidiary). The amendment modifies the original merger agreement dated June 23, 2026, and replaces the form of the A&R LLC Agreement to clarify certain redemption mechanics and replaces the form of Parent New Charter to provide for a proposed amendment to the requirements for HeartSciences shareholder action by written consent. The amendment also adjusts the merger consideration calculation and adds provisions for adjustments in the event of a reverse stock split.
  https://www.sec.gov/Archives/edgar/data/1468492/0001213900-26-081825.txt
- 2026-07-29 · 8-K (0001213900-26-082577): 8-K - HeartSciences Inc. — *HeartSciences Inc. is a healthcare information technology company focused on advancing electrocardiography (ECG/EKG) through the integration of artificial intelligence; its MyoVista Insights platform is a device-agnostic ECG management system, and its MyoVista wavECG device is under FDA review for 510(k) clearance.* HeartSciences Inc., a healthcare information technology company focused on electrocardiography and artificial intelligence, entered into a definitive merger agreement with Fortitude Mining Holdings, Inc. on June 23, 2026, to combine in an all-stock transaction. Under the proposed transaction, HeartSciences will issue approximately 107.6 million shares of a new Class V Common Stock to Digital Currency Group (DCG), Fortitude's parent company. The pro forma combined entity will have total shareholders' equity of $70.0 million. The transaction is subject to HeartSciences shareholder approval at a special meeting, and the parties have also proposed a reverse stock split authorization at a ratio between 1-for-2 and 1-for-5 to satisfy Nasdaq listing requirements for the combined company.
  https://www.sec.gov/Archives/edgar/data/1468492/0001213900-26-082577.txt

## Citations
- 0001213900-26-081825 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026081825
- 0001213900-26-082577 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026082577